CHOLINESTERASE INHIBITORS AND MEMANTINE FOR THE TREATMENT OF ALZHEIMER AND NON-ALZHEIMER DEMENTIAS

被引：21
|
作者：
Balazs, Nora [1 ]
Bereczki, Daniel [1 ,2 ]
Kovacs, Tibor [1 ,2 ]
机构：
[1] Semmelweis Univ, Dept Neurol, Balassa U 6, H-1083 Budapest, Hungary
[2] MTA SE Neuroepidemiol Res Grp ELKH, Budapest, Hungary
来源：
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE | 2021年 / 74卷 / 11-12期
关键词：
dementia; therapy; treatment; cholinesterase inhibitors; memantine; ACETYLCHOLINESTERASE INHIBITORS; ANTIDEMENTIA DRUGS; DISEASE; ASSOCIATION; DIAGNOSIS; MODERATE; RIVASTIGMINE; MANAGEMENT; ATROPHY;
D O I：
10.18071/isz.74.0379
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In aging societies, the morbidity and mortality of dementia is increasing at a significant rate, thereby imposing burden on healthcare, economy and the society as well. Patients' and caregivers' quality of life and life expectancy are greatly determined by the early diagnosis and the initiation of available symptomatic treatments. Cholinesterase inhibitors and memantine have been the cornerstones of Alzheimer's therapy for approximately two decades and over the years, more and more experience has been gained on their use in non-Alzheimer's dementias too. The aim of our work was to provide a comprehensive summary about the use of cholinesterase inhibitors and memantine for the treatment of Alzheimer's and non-Alzheimers's dementias.
引用
收藏
页码：379 / 387
页数：9
相关论文
共 50 条
  • [31] Neuroscintigraphy of Non-Alzheimer's Disease Dementias
    Wang, K.
    Dai, Y. L.
    Cheung, T. C. Y.
    Dai, D. L. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2015, 18 (01): : 74 - 86
  • [32] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
    Parsons, Chris G.
    Danysz, Wojciech
    Dekundy, Andrzej
    Pulte, Irena
    NEUROTOXICITY RESEARCH, 2013, 24 (03) : 358 - 369
  • [33] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
    Chris G. Parsons
    Wojciech Danysz
    Andrzej Dekundy
    Irena Pulte
    Neurotoxicity Research, 2013, 24 : 358 - 369
  • [34] A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease
    Ebrahem, Anees Shajhan
    Oremus, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1245 - 1259
  • [35] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Rabins, Peter V.
    Lyketsos, Constantine G.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (11): : 578 - 579
  • [36] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Peter V Rabins
    Constantine G Lyketsos
    Nature Clinical Practice Neurology, 2006, 2 : 578 - 579
  • [37] Cholinergic approaches to behavioral symptoms in non-Alzheimer dementias
    Kaufer, D
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 382 - 382
  • [38] Functional imaging techniques in the diagnosis of non-Alzheimer dementias
    Brooks, DJ
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1996, (47): : 155 - 167
  • [39] CERAD DIAGNOSIS OF NON-ALZHEIMER DEMENTIAS - STANDARDIZATION AND TRAINING
    MORRIS, JC
    HEYMAN, A
    HENDRIE, H
    NEUROBIOLOGY OF AGING, 1994, 15 : S32 - S33
  • [40] APOE epsilon 4 allele in Alzheimer's and non-Alzheimer's dementias
    Itabashi, S
    Arai, H
    Higuchi, S
    Sasaki, H
    Trojanowski, JQ
    LANCET, 1996, 348 (9032): : 960 - 961
12345